Although improving, the pharma sector still has social and environmental challenges to address. Nina Röhrbein reports
Already an IPE Member? Sign in here
For unlimited access to IPE’s industry-leading market intelligence, comprising news, data and long-form content on European pensions and institutional investment.
IPE has created a suite of products and services for Europe’s institutional investment and pensions community.